A neutralizing monoclonal antibody targeting species B adenoviruses largely mimics the DSG2 receptor engagement mechanism
Vassal-Stermann et al. identified two monoclonal antibodies that neutralize HAdV7 and cross-react with pathogenic species B adenoviruses.